# Nationwide Analysis of In-Hospital Mortality in Patients with Encephalitis-Related Diagnoses in Ecuador

**Authors:** Karime Montes-Escobar, Christian Eduardo Ramirez-Veloz, Maribel Cecilia Pérez-Pirela, Roy Lincoln Solórzano Giler, Felix Vicente Zambrano Pico, Fanny Soraya Reyes-Mena, Julio Torres, Yulixis Cano, Aline Siteneski

PMC · DOI: 10.3390/diseases14020082 · 2026-02-21

## TL;DR

This study analyzed hospitalization and mortality patterns for encephalitis-related diagnoses in Ecuador from 2018 to 2024, revealing age and ethnic disparities.

## Contribution

The study provides the first nationwide epidemiological analysis of encephalitis-related hospitalizations and mortality in Ecuador, highlighting sociodemographic risk factors.

## Key findings

- Unspecified encephalitis and encephalomyelitis were the most common diagnoses in Ecuador.
- Patients aged ≥70 had the highest mortality risk, with an adjusted odds ratio of 0.265.
- Indigenous individuals were more likely to be diagnosed with acute disseminated encephalitis.

## Abstract

Background/Objectives: Encephalitis and related acute encephalopathic syndromes represent severe neurological conditions with diverse etiologies and variable clinical outcomes. This study aimed to analyze nationwide hospitalization patterns for encephalitis-related diagnoses in Ecuador between 2018 and 2024. Methods: We used data from the Ecuadorian National Institute of Statistics and Census to estimate age-adjusted hospitalization and mortality rates according to ICD-10 codes. Binary and multinomial logistic regression models were employed to identify sociodemographic factors and diagnostic categories of encephalitis associated with hospitalization and in-hospital mortality. Results: A total of 1560 hospitalizations related to encephalitis-spectrum diagnoses were recorded, with an overall age-adjusted rate of 0.127 per 100,000 inhabitants and 6.0% in-hospital mortality. Unspecified encephalitis and encephalomyelitis were the most common diagnostic categories. Adolescents (10–19 years) were more frequently diagnosed with acute disseminated and bacterial meningoencephalitis, while patients aged ≥70 had higher odds of “other” encephalitis subtypes and the highest mortality risk (aOR = 0.265; 95% CI: 0.116–0.608). Indigenous individuals were more likely to be diagnosed with acute disseminated encephalitis, and Black individuals showed a higher risk for myelopathy associated with human T-cell lymphotropic virus type 1-associated myelopathy. Conclusions: Age and ethnicity significantly influence hospitalization due to encephalitis-related diagnoses in Ecuador. These findings provide epidemiological rates for a lower-middle–income country where the lack of precise diagnosis, age, and ethnicity contribute to the vulnerability of encephalitis.

## Linked entities

- **Diseases:** encephalitis (MONDO:0019956), acute disseminated encephalitis (MONDO:0019383)

## Full-text entities

- **Genes:** LGI1 (leucine rich glioma inactivated 1) [NCBI Gene 9211] {aka ADLTE, ADPAEF, ADPEAF, DEE121, EPITEMPIN, EPT}
- **Diseases:** myelitis (MESH:D009187), bacterial infections (MESH:D001424), Acute disseminated encephalitis (MESH:D000071072), HSV encephalitis (MESH:D020803), neurological deficits (MESH:D009461), disseminated (MESH:D009103), Acute disseminated encephalomyelitis (MESH:D004673), seizures (MESH:D012640), fungal (MESH:D009181), fever (MESH:D005334), tick- and squirrel-borne virus encephalitis (MESH:D004675), myelopathy (MESH:D013118), neurological impairment (MESH:D009422), paraneoplastic (MESH:D010257), coma (MESH:D003128), disability (MESH:D009069), Encephalitic syndromes (MESH:D010301), infectious (MESH:D003141), neurological conditions (MESH:D019636), injury to (MESH:D014947), headache (MESH:D006261), acute inflammation (MESH:D007249), Bacterial meningoencephalitis (MESH:D008590), encephalopathy (MESH:D001927), influenza (MESH:D007251), autoimmune encephalitis (MESH:D020274), Deaths (MESH:D003643), viral (MESH:D014777), encephalomyelitis (MESH:D004679), behavioral abnormalities (MESH:D001523), infection (MESH:D007239), Encephalitis (MESH:D004660), meningomyelitis (MESH:D013606), COVID-19 (MESH:D000086382), HSV (MESH:D006561), HTLV-associated myelopathy (MESH:D015493), pleocytosis (MESH:D007964), meningitis (MESH:D008580)
- **Chemicals:** G042 (-)
- **Species:** Human T-cell lymphotropic virus (no rank) [taxon 1907191], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Streptococcus (genus) [taxon 1301], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Mycoplasmoides pneumoniae (Filterable agent of primary atypical pneumonia, species) [taxon 2104], Human T-cell leukemia virus type I (no rank) [taxon 11908], Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12939478/full.md

---
Source: https://tomesphere.com/paper/PMC12939478